Australia Stock Exchange release from EMYRIA : Emyria adds wearables to psychedelic-assisted therapy trials
19/12/2021 22:10
Australia Stock Exchange release from EMYRIA EMD.AX : Emyria adds wearables to psychedelic-assisted therapy trials
- AU$30.65m
- AU$24.15m
- AU$4.05m